NCT04367077View on ClinicalTrials.gov

MultiStem Administration for COVID-19 Induced ARDS (MACoVIA)

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

January 31, 2023

Study Completion Date

December 31, 2023

Conditions
ARDS
Interventions
BIOLOGICAL

MultiStem

intravenous infusion

BIOLOGICAL

Placebo

intravenous infusion

Trial Locations (4)

44106

RECRUITING

Athersys Investigational Site 101, Cleveland

44109

RECRUITING

Athersys Investigational Site 102, Cleveland

44304

RECRUITING

Athersys Investigational Site 103, Akron

60601

RECRUITING

Athersys Investigational Site 107, Chicago

Sponsors

Lead Sponsor

Healios K.K.
All Listed Sponsors
lead

Healios K.K.

INDUSTRY

NCT04367077 - MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | Biotech Hunter | Biotech Hunter